Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Mesoblast

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Mesoblast

Regulatory records
1
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 1 FDA record to the applicant name Mesoblast. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Dec 23, 2025 to Dec 23, 2025. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code MOZ appears in 1 of the 1 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P170016, with 1 linked entry. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: Level 38, 55 Collins St., Melbourne, 3000. Recorded on P170016/S001, decision dated Dec 23, 2025.

Changes described in PMA records

P170016/S001: SYNOJOYNT

FDA’s recorded scope: Approval for the replacement and relocation of the blistering and labeling equipment and minor change to process and size of label.

Dec 23, 2025 · 30-Day Notice

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Devices & associated records

Product / regulatory recordCompanyPathwayDecision dateSource
SYNOJOYNTP170016/S001
MesoblastPMA supplementDec 23, 2025FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.